Established Investigator grant for Amanda Foks

Amanda Foks (Div. of BioTherapeutics) has been awarded over 920.000 euro from the Dutch Heart Foundation to advance her research on age-associated B cell immunity in atherosclerotic cardiovascular disease in the coming 5 years. The Established Investigator grant will allow her to investigate the mechanism-of-action of age-associated B cells in atherosclerosis and to modulate these B cells to combat atherosclerosis.  

Link to Hartstichting article: Hartstichting Dekkerbeurzen: 3,6 miljoen euro voor onderzoek | Hartstichting

Link to Leiden University article: Over €900,000 awarded for new treatment against atherosclerosis – Leiden University

Funded by the European Union under Grant Agreement No. 101115159.
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Innovation Council and SMEs Executive Agency (EISMEA). Neither the European Union nor the granting authority can be held responsible for them.

© 2026 Bspecific. All rights reserved